Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2018 Annual Meeting | C194 - Actualización Sobre el Manejo del Ictus Cerebrovascular

Thursday 04/26/18
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Carlos S. Kase, MD, FAHA, FÂ鶹´«Ã½Ó³»­
Al completar el programa, los participantes debieran estar al día en los aspectos básicos de la terapia del ictus isquémico y hemorrágico, incluyendo la última información relacionada con el manejo neuro-intervencionista del ictus isquémico agudo, opciones para el tratamiento del ictus relacionado a la presencia de un foramen oval permeable, y manejo de la presión arterial en la etapa inicial del ictus hemorrágico intraparenquimatoso.
2.00 CME credits
Patient Care & Procedural Skills
Neurohospitalist, Spanish Language
Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist
Case-based, Didactic, Interactive, Audience Participation
Event Timeline
01:00 PM - 01:05 PM Speaker Introducción
Carlos S. Kase, MD, FAHA, FÂ鶹´«Ã½Ó³»­
01:05 PM - 01:50 PM Speaker Actualización en Ictus Isquémico
Jose G. Romano, MD, FÂ鶹´«Ã½Ó³»­
01:50 PM - 02:35 PM Speaker Actualización en Ictus Hemorrágico
Carlos S. Kase, MD, FAHA, FÂ鶹´«Ã½Ó³»­
02:35 PM - 02:55 PM Speaker Discusión de Casos Clínicos
Enrique C. Leira, MD, MS, FÂ鶹´«Ã½Ó³»­
02:55 PM - 03:00 PM Closing Remarks Conclusión
Carlos S. Kase, MD, FAHA, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Carlos S. Kase, MD, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Kase has nothing to disclose.
Enrique C. Leira, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS.
Jose G. Romano, MD, FÂ鶹´«Ã½Ó³»­ Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.